Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001213900-25-003855
Filing Date
2025-01-15
Accepted
2025-01-15 16:25:12
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13D/A  
1 primary_doc.xml SCHEDULE 13D/A 10724
  Complete submission text file 0001213900-25-003855.txt   12247
Mailing Address 36 WOODMAN ROAD CHESTNUT HILL MA 02467
Business Address
SPRINGER TIMOTHY A (Filed by) CIK: 0001055624 (see all company filings)

Type: SCHEDULE 13D/A

Mailing Address 7495 NEW HORIZON WAY FREDERICK MD 21703
Business Address 7495 NEW HORIZON WAY FREDERICK MD 21703 301-348-8698
Cartesian Therapeutics, Inc. (Subject) CIK: 0001453687 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13D/A | Act: 34 | File No.: 005-89550 | Film No.: 25533203
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)